Inflammatory bowel disease (IBD) is a term for two conditions (Crohn disease and ulcerative colitis) that are characterized by chronic inflammation of the gastrointestinal tract. Development of IBD has both genetic and environmental components, including the intestinal microbiome, defects in barrier function, and dysregulated host responses to microbial stimulation. Single gene defects impact a subset of patients with inflammatory bowel disease, particularly those with early-onset disease. The OMIM phenotypic series for this disease defines several implicated genes and many susceptibility loci; see the link below.
[updated Nov. 2018 by FlyBase; FBrf0222196]
Inflammatory bowel disease is characterized by a chronic relapsing intestinal inflammation. IBD is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease and ulcerative colitis have a combined prevalence of 200 to 300 per 100,000 in the United States. Crohn disease may involve any part of the gastrointestinal tract, but most frequently the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. In approximately 10% of cases confined to the rectum and colon, definitive classification of Crohn disease or ulcerative colitis cannot be made and are designated 'indeterminate colitis.' Both diseases include extraintestinal inflammation of the skin, eyes, or joints. [from MIM:266600; 2018.11.09]
Inflammatory bowel disease is most often a polygenic disorder with contributions from the intestinal microbiome, defects in barrier function, and dysregulated host responses to microbial stimulation. There is, however, increasing recognition of single gene defects that underlie a subset of patients with inflammatory bowel disease, particularly those with early-onset disease (Kelsen and Sullivan, 2017; pubmed:28755025).
There is strong evidence from twin studies, familial risk data, and segregation analysis that susceptibility to inflammatory bowel disease, especially Crohn disease, is genetic (Yang and Rotter, 1994; Duerr, 1996, pubmed:23282455). [from MIM:266600; 2018.11.09]
Crohn disease and ulcerative colitis are commonly classified as autoimmune diseases. The prevalence of inflammatory bowel disease is increased in individuals with other autoimmune diseases. [from MIM:266600; 2018.11.09]